Press Releases
SMi present the 13th annual event – Advances and...
SPONSORED BY CHEMICAL COMPUTING GROUPSMi are proud to present the 13th annual Advances and Progress in Drug Design conference, convening in Central London on Monday...
Press Releases
Agilent Technologies and Seoul National University Hospital Collaborate on...
Agilent Technologies Inc. and Seoul National University Hospital one of Korea’s top medical centers today announced a strategic collaboration for the development and verification of...
Press Releases
Nosopharm receives EUR 870,000 (USD 1.18 million) to help...
Nosopharm specializes in the research and development of new anti-infective drugs, today announces that it has secured funding of EUR 870,000 (USD 1.18 million). ...
Press Releases
Secukinumab showed superiority over Enbrel®
Novartis announced results from the head-to-head Phase III FIXTURE study showing secukinumab an interleukin-17A inhibitor, was significantly superior to Enbrel in moderate-to-severe plaque psoriasis. ...
Press Releases
2013 Utah Life Science Summit Features Top State and...
BioUtah today released the agenda for the 2013 Utah Life Science Summit Utah’s premier life science event which will be held all day November 6...
Press Releases
Lannett Announces Proposed Public Offering of Common Stock
Lannett Company Inc. today announced that it and certain selling stockholders intend to offer shares of the Company’s common stock in an underwritten public offering....
Press Releases
Cancer Vaccine Company DCPrime and Janssen To Collaborate on...
Cancer vaccine company DCPrime BV today announced that it has entered into a research and optional license agreement with Janssen Pharmaceuticals Inc. The collaboration has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.